Detalles de la búsqueda
1.
Preoperative Treatment of Locally Advanced Rectal Cancer.
N Engl J Med
; 389(4): 322-334, 2023 Jul 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37272534
2.
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study.
Lancet
; 402(10395): 41-53, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37331369
3.
Fragmentation of Care in Patients with Peritoneal Metastases Undergoing Cytoreductive Surgery.
Ann Surg Oncol
; 31(1): 645-654, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37737968
4.
Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: a pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur).
BMC Cancer
; 24(1): 201, 2024 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38350888
5.
Role of Tumor-informed Personalized Circulating Tumor DNA Assay in Informing Recurrence in Patients With Peritoneal Metastases From Colorectal and High-grade Appendix Cancer Undergoing Curative-intent Surgery.
Ann Surg
; 278(6): 925-931, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36994703
6.
PI3K Pathway Alterations in Peritoneal Metastases are Associated with Earlier Recurrence in Patients with Colorectal Cancer Undergoing Optimal Cytoreductive Surgery.
Ann Surg Oncol
; 30(5): 3114-3122, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36637640
7.
Mutational profiles and prognostic impact in colorectal and high-grade appendiceal adenocarcinoma with peritoneal metastases.
J Surg Oncol
; 127(5): 831-840, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36636792
8.
Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) Levels.
Ann Surg Oncol
; 2022 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34988836
9.
Novel Application of Iterative Hyperthermic Intraperitoneal Chemotherapy for Unresectable Peritoneal Metastases from High-Grade Appendiceal Ex-Goblet Adenocarcinoma.
Ann Surg Oncol
; 28(3): 1777-1785, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32892267
10.
Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery: ERAS for Patients Undergoing Cytoreductive Surgery with or Without HIPEC.
Ann Surg Oncol
; 28(12): 6955-6964, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33954868
11.
A multi-institutional comparison of mitoxantrone, etoposide, and cytarabine vs high-dose cytarabine and mitoxantrone therapy for patients with relapsed or refractory acute myeloid leukemia.
Am J Hematol
; 95(8): 937-943, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32311140
12.
ASO Author Reflections: Fragmented Care in Patients with Peritoneal Metastases.
Ann Surg Oncol
; 31(1): 655-656, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37803088
13.
ASO Visual Abstract: PI3K Pathway Alterations in Peritoneal Metastases are Associated with Earlier Recurrence for Patients with Colorectal Cancer Undergoing Optimal Cytoreductive Surgery.
Ann Surg Oncol
; 30(5): 3123-3124, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36641511
14.
ASO Visual Abstract: Phase II Prospective Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy with and without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels.
Ann Surg Oncol
; 29(Suppl 3): 616-617, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35930113
15.
Investigating the Use of Circulating Tumor DNA in Early-Stage Colon Cancer.
Oncology (Williston Park)
; 36(10): 620-626, 2022 10 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36260785
16.
Colorectal Cancer: Genetic Underpinning and Molecular Therapeutics for Precision Medicine.
Genes (Basel)
; 15(5)2024 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38790167
17.
Utility of Circulating Tumor DNA Assessment in Characterizing Recurrence Sites after Optimal Resection for Metastatic Colorectal Cancer.
J Am Coll Surg
; 238(6): 1013-1020, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38299640
18.
Radiation Therapy Quality Assurance Analysis of Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Pancreas.
Int J Radiat Oncol Biol Phys
; 2024 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38492812
19.
Multi-Institutional Study Evaluating the Role of Circulating Tumor DNA in the Management of Appendiceal Cancers.
JCO Precis Oncol
; 8: e2300531, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38723230
20.
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study.
J Clin Oncol
; : JCO2302736, 2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38833658